Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $132.48 USD
Change Today +1.20 / 0.91%
Volume 950.9K
As of 8:04 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

core laboratories n.v. (CLB) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/8/14 - $194.04
52 Week Low
01/29/15 - $87.27
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CORE LABORATORIES N.V. (CLB)

core laboratories n.v. (CLB) Related Bloomberg News

View More Bloomberg News

core laboratories n.v. (CLB) Related Businessweek News

No Related Businessweek News Found

core laboratories n.v. (CLB) Details

Core Laboratories N.V. provides reservoir description, production enhancement, and reservoir management services to the oil and gas industry in the United States, Canada, and internationally. The company’s Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples. This segment offers analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. Its Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations, and production. This segment offers integrated services to evaluate the effectiveness of well completions and to develop solutions to enhance the effectiveness of enhanced oil recovery projects. The company’s Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase the production and improve recovery of oil and gas from its client’s reservoirs. It markets its products through sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.

5,000 Employees
Last Reported Date: 02/17/15
Founded in 1936

core laboratories n.v. (CLB) Top Compensated Officers

Chairman of Supervisory Board, Chief Executiv...
Total Annual Compensation: $951.0K
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: $508.6K
Chief Operating Officer and Senior Vice Presi...
Total Annual Compensation: $508.6K
Compensation as of Fiscal Year 2014.

core laboratories n.v. (CLB) Key Developments

Core Laboratories Reports Unaudited Condensed Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Second Quarter and Full Year of 2015

Core Laboratories NV reported unaudited condensed consolidated earnings results for the first quarter ended March 31, 2015. For the period, the company has posted revenue of $213,643,000 against $262,903,000 a year ago. Operating income was $42,717,000 against $82,827,000 a year ago. Income before income tax expense was $40,314,000 against $80,464,000 a year ago. Net income was $31,042,000 against $61,153,000 a year ago. Net income attributable to Core Laboratories N.V. was $31,399,000 against $61,064,000 a year ago. Diluted earnings per share were $0.72 against $1.35 a year ago. Cash flows from operating activities were $79,578,000 a year ago. Capital expenditures were $6,869,000. The company provided earnings guidance for the second quarter and full year of 2015. The company projects EPS ranging between $0.76 and $0.81. Free cash flow for the second quarter is expected to exceed $60 million, significantly greater than projected net income. And all operational guidance excludes any foreign currency translation and any shares that may be repurchased other than those already disclosed and it assumes an effective tax rate in the quarter of 22.5%. The company expects CapEx program in 2015 to track client demand for services and products. So consequently, the company expects CapEx in 2015 to be lower than 2014.

Core Laboratories NV Declares Second Quarter Cash Dividend Payable on May 22, 2015

The Board of Supervisory Directors of Core Laboratories N.V. has announced a cash dividend of $0.55 per share of common stock payable in the second quarter of 2015. On an annualized basis, this second quarterly dividend would equal a total payout of $2.20 per share of common stock, if maintained for the entire year. The quarterly $0.55 per share cash dividend will be payable on 22 May 2015, to shareholders of record on 24 April 2015.

Core Laboratories NV to Report Q1, 2015 Results on Apr 22, 2015

Core Laboratories NV announced that they will report Q1, 2015 results at 5:00 PM, W. Europe Standard Time on Apr 22, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLB:US $132.48 USD +1.20

CLB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ALS Ltd A$5.48 AUD -0.15
Eurofins Scientific SE €251.70 EUR +2.80
Intertek Group PLC 2,626 GBp +14.00
Petroleum Geo-Services ASA 49.88 NOK +5.26
TGS Nopec Geophysical Co ASA 191.40 NOK +7.40
View Industry Companies

Industry Analysis


Industry Average

Valuation CLB Industry Range
Price/Earnings 25.7x
Price/Sales 5.6x
Price/Book 176.9x
Price/Cash Flow 22.3x
TEV/Sales 5.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CORE LABORATORIES N.V., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at